Enric Rello Condomines
Director of Finance/CFO bei ORYZON GENOMICS S.A.
Profil
Enric Rello Condomines is currently the Chief Operating & Financial Officer at Oryzon Genomics SA. He is also a Professor at Universitat Abat Oliba CEU.
Previously, he worked as the Finance Director at Sandoz Industrial Products SA from 1993 to 2007.
Dr. Rello Condomines completed his undergraduate degree at the University of Barcelona and holds undergraduate, graduate, and doctorate degrees from Universitat Abat Oliba CEU.
Aktive Positionen von Enric Rello Condomines
| Unternehmen | Position | Beginn |
|---|---|---|
| ORYZON GENOMICS S.A. | Director of Finance/CFO | 01.05.2011 |
| Universitat Abat Oliba CEU | Corporate Officer/Principal | - |
Ehemalige bekannte Positionen von Enric Rello Condomines
| Unternehmen | Position | Ende |
|---|---|---|
Sandoz Industrial Products SA
 Sandoz Industrial Products SA Pharmaceuticals: MajorHealth Technology Sandoz Industrial Products SA engages in the manufacture and commercialization of pharmaceutical products. These include generic drugs, anti-infectives, and biosimilars for the treatment of cardiovascular, gastrointestinal, respiratory, and hematological conditions. The company was founded in 1966 and is headquartered in Palafolls, Spain. | Director of Finance/CFO | 01.01.2007 |
Ausbildung von Enric Rello Condomines
| University of Barcelona | Undergraduate Degree |
| Universitat Abat Oliba CEU | Doctorate Degree |
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
Beziehungen ersten Grades
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
| Börsennotierte Unternehmen | 1 |
|---|---|
| ORYZON GENOMICS S.A. | Health Technology |
| Private Unternehmen | 1 |
|---|---|
Sandoz Industrial Products SA
Sandoz Industrial Products SA Pharmaceuticals: MajorHealth Technology Sandoz Industrial Products SA engages in the manufacture and commercialization of pharmaceutical products. These include generic drugs, anti-infectives, and biosimilars for the treatment of cardiovascular, gastrointestinal, respiratory, and hematological conditions. The company was founded in 1966 and is headquartered in Palafolls, Spain. | Health Technology |
